Endo International Plc (ENDPQ) Directors and Executive Officers - CSIMarket
CSIMarket
 
Endo International Plc  (ENDPQ)

Endo International Plc

Officers & Directors


Blaise Coleman
President and Chief Executive Officer - (Principal Executive Officer)
Blaise Coleman has been the President and Chief Executive Officer of Endo International since . As a seasoned industry veteran, he has over 30 years of experience in the pharmaceutical industry. Before joining Endo, he worked at Pfizer for nearly 20 years, most recently as the Senior Vice President and Global Head of Rare Diseases.

Mark T. Bradley
Executive Vice President, Chief Financial Officer - (Principal Financial Officer)
Mark T. Bradley has served as the Executive Vice President and Chief Financial Officer at Endo International. He has also worked with in Philadelphia, Pennsylvania.

Matthew J. Maletta
Attorney-in-fact pursuant to a Power of Attorney filed with this Report as - Exhibit.

Frank B. Raciti
Vice President, Controller, Chief Accounting Officer - (Principal Accounting Officer)

Paul Campanelli
Chairman of the Board
Paul Campanelli is the Chairman of the Board of Endo International. He was the company’s Chief Executive Officer from 2016 to 2020 and is now a strategic advisor to the company. Before joining Endo, he served as the President of the Generic Pharmaceuticals business unit of Teva Pharmaceuticals.

Roger H. Kimmel
Director
Roger H. Kimmel is a Director of Endo International. He is also a member of the Audit and Finance Committee and the Governance and Nominating Committee. He is a biotech and pharmaceutical industry veteran and has held several leadership positions, including Chief Executive Officer of Searle Pharmaceuticals.

Nancy J. Hutson
Director
Nancy J. Hutson is a Director of Endo International. She is also a member of the Audit and Finance Committee and the Governance and Nominating Committee. She has spent over 25 years in healthcare and related industries and has held executive leadership positions in companies such as McKesson Corporation and Pfizer.

Sharad Mansukani
Executive Vice President and Chief Medical Officer
Sharad Mansukani is the Executive Vice President and Chief Medical Officer of Endo International. He oversees the company’s global clinical development and medical affairs. Before joining Endo, he worked at Shire Pharmaceuticals, where he held several senior leadership roles in clinical development, medical affairs, and regulatory affairs.,

Endo International Plc currently has 2931 employees.






ENDPQ Management Effectiveness ENDPQ Revenue per Employee ENDPQ Income per Employee


Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.